{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:22:56Z","timestamp":1784193776269,"version":"3.55.0"},"reference-count":33,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2005,6,15]],"date-time":"2005-06-15T00:00:00Z","timestamp":1118793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Euro J of Neurology"],"published-print":{"date-parts":[[2005,7]]},"abstract":"<jats:p>Linezolid, an oxazolidinone, exhibits bacteriostatic activity against virtually all Gram\u2010positive bacteria and even covers atypical organisms like mycobacteria and <jats:italic>Nocardia<\/jats:italic>. However, little is known about its effectiveness for central nervous system (CNS) infections. We report on our good experience with linezolid for the treatment of CNS infections in 10 patients, amongst whom three were caused by mycobacteria. While six of our patients clinically improved during linezolid therapy even after failure of various antibiotics, it was unsuccessful in one case. Side\u2010effects were only mild gastrointestinal problems in one patient after long term\u2010treatment, which however led to the cessation of therapy. Linezolid appears to be a safe alternative to vancomycin for therapy\u2010resistant CNS infections because of its good CSF penetration and few side\u2010effects.<\/jats:p>","DOI":"10.1111\/j.1468-1331.2005.01001.x","type":"journal-article","created":{"date-parts":[[2005,6,15]],"date-time":"2005-06-15T15:53:15Z","timestamp":1118850795000},"page":"536-542","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Clinical experience with linezolid for the treatment of central nervous system infections"],"prefix":"10.1111","volume":"12","author":[{"given":"T. A.","family":"Rupprecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.\u2010W.","family":"Pfister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2005,6,15]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.43.4.876"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1053\/jinf.2001.0863"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1086\/322523"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.47.5.1736-1738.2003"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/46.6.981"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06964-1"},{"issue":"2","key":"e_1_2_6_8_1","first-page":"ii45","article-title":"Safety and tolerability of linezolid","volume":"51","author":"French G","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.8.2723-2726.2002"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/jinf.2002.0979"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2003.98.1.0008"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s100960100512"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200203143461121"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-002-0807-0"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0732-8893(02)00523-0"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199711000-00010"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.2.929-932.2004"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1053\/jinf.2002.1122"},{"issue":"2","key":"e_1_2_6_19_1","first-page":"ii9","article-title":"Linezolid in vitro: mechanism and antibacterial spectrum","volume":"51","author":"Livermore DM","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-138-2-200301210-00015"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1086\/345907"},{"key":"e_1_2_6_22_1","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1128\/AAC.43.8.1932","article-title":"Bactericidal activity of vancomycin in cerebrospinal fluid","volume":"43","author":"Nagl M","year":"1999","journal-title":"Antimicrob Agents Chemother"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/35.5.675"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1086\/513756"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2003.98.5.1040"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365540410019345"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-8579(03)00048-7"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1080\/003655401750174048"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-200112000-00023"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05410-1"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/00365540110080467"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.46.3.936-937.2002"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.3.764-767.2001"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1086\/321896"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2005.01001.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-1331.2005.01001.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T01:33:58Z","timestamp":1696901638000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2005.01001.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,15]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["10.1111\/j.1468-1331.2005.01001.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2005.01001.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101","1468-1331"],"issn-type":[{"value":"1351-5101","type":"print"},{"value":"1468-1331","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,15]]},"assertion":[{"value":"2005-06-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}